It takes an "A" team to make headway against glioblastoma, a highly aggressive type of brain cancer.

Glioblastoma is the most common type of malignant brain tumor in adults.

It is aimed at helping researchers and physicians improve the diagnosis and treatment of glioblastoma, including finding new drug targets.

While Atlas-based data have been previously available, the new paper in Science represents the first published research outlining the project in detail.

The first is to make all the relevant data fully transparent and available.

By identifying unique features of these tumors that may benefit from targeted therapies, the Atlas will enable patients to experience the benefits of precision medicine, increasing the chances for better response to treatment and hence better survival."

The text above is a summary, you can read full article here.